Market Overview

GTSO: U.S. Medical Cannabis Industry Opens Up Shop in New York

Share:
SAN JOSE, Calif.--(BUSINESS WIRE)--

New York state opened its first medical cannabis dispensaries last week, joining 22 other states in making the plant available to patients suffering from illnesses such as cancer, AIDS and more. As the regulated market for cannabis continues to rapidly expand across the country, Green Technology Solutions, Inc. (OTCQB: GTSO) is working hard to increase its footprint within the industry—one of the fastest-growing in North America.

New York's medical cannabis program features tight controls. The state prohibits cannabis for smoking. Cannabis products can only be sold in liquid or oil form for use in inhalers, vaporizers and capsules. Cultivation of the plant by patients is prohibited.

GTSO is currently working to deliver new products that are similarly designed to help restrict access to medical cannabis—specifically, from children. In partnership with 3D printing company 6th Dimension Technologies, GTSO is now producing prototypes of multiple child-proof cannabis containers featuring a variety of locking mechanisms. These new solutions are custom designed to keep cannabis—including vaporizers, oils and liquids—out of the hands of kids.

"As the demand for medical cannabis rises, so too does demand for products that prevent cannabis from being mishandled or misused," said GTSO CEO Wallace W. Browne. "We are working on some very promising designs at the moment, and we expect to announce our first patent soon."

As the market for medical cannabis and related products continues to grow in New York and across the country, GTSO plans to introduce an entire suite of new tools to help cannabis wholesalers, retailers and consumers safeguard the potency, consistency and safety of their products.

About Green Technology Solutions, Inc.

Green Technology Solutions, Inc., which provides business support, delivery system products and horticultural technology support, continually introduces new products and services, enabling it to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC) and others in a booming industry expected to be $10 billion by 2018. A growth-oriented company, Green Technology Solutions Inc. (GTSO) explores the fast-growing cannabis market for resources, including but not limited to rare earth elements, precious metals and herbal supplements. For more information, visit www.gtsoresources.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Green Technology Solutions, Inc.
Wallace W. Browne, 408-432-7285
President and CEO
info@gtsoresources.com

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com